{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:34:24Z","timestamp":1789835664903,"version":"4.0.1"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1,24]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Locked-in syndrome (and its variant, completely locked-in state) generally has a high mortality rate in the acute setting; however, when induced by conditions such as acute inflammatory polyradiculoneuropathy, it may well be curable such that an attempt at cure should be systematically sought by clinicians.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 52-year-old man presented with acute tetraparesia and areflexia, initially diagnosed as Guillain\u2013Barr\u00e9 syndrome. Despite appropriate treatment, his condition deteriorated, evolving into a completely locked-in state.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>The detection of anti-pan-neurofascin antibodies led to the correct diagnosis, acute pan-neurofascin autoimmune nodoparanodopathy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Immunosuppressive treatment (rituximab) and plasma exchanges were performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>After several months, the patient\u2019s neurological symptoms almost completely subsided, without any major sequelae.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>In patients with locked-in syndrome (or its variant), neurologists and intensive care physicians must be aware of, and look for, the main etiologies (including pan-neurofascin autoimmune nodoparanodopathy), to allow the prompt initiation of treatment and thus a rapid recovery for these ultimately curable conditions. Despite causing major disability, pan-neurofascin autoimmune nodoparanodopathy is curable if the appropriate treatment is given.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000041304","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T23:00:50Z","timestamp":1737759650000},"page":"e41304","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Pan-neurofascin autoimmune nodoparanodopathy: A case report and literature review"],"prefix":"10.1097","volume":"104","author":[{"given":"Elsa","family":"Krim","sequence":"first","affiliation":[{"name":"Department of Neurology, Pau Hospital, Pau, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Masri","sequence":"additional","affiliation":[{"name":"Department of Reanimation, Pau Hospital, Pau, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilien","family":"Delmont","sequence":"additional","affiliation":[{"name":"Department of Neurology (Nerve-Muscle Unit), Reference Center for Neuromuscular Diseases, University Hospitals of Marseille, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendal","family":"Le Masson","sequence":"additional","affiliation":[{"name":"Department of Neurology (Nerve-Muscle Unit), Reference Center for Neuromuscular Diseases \u201cAOC,\u201d ALS Reference Center, University Hospitals of Bordeaux (Pellegrin Hospital), University of Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Boucraut","sequence":"additional","affiliation":[{"name":"Department of Immunology, INS Institut de Neurosciences des Syst\u00e8mes \u2013 INSERM U 1106 (Physionet Team), University Hospitals of Marseille, Marseille, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0775-4625","authenticated-orcid":false,"given":"St\u00e9phane","family":"Mathis","sequence":"additional","affiliation":[{"name":"Department of Neurology (Nerve-Muscle Unit), Reference Center for Neuromuscular Diseases \u201cAOC,\u201d ALS Reference Center, University Hospitals of Bordeaux (Pellegrin Hospital), University of Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250124","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/jnnp-2021-326889","article-title":"New classification of autoimmune neuropathies based on target antigens and involved domains of myelinated fibres.","volume":"93","author":"Uncini","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R2-20250124","doi-asserted-by":"crossref","first-page":"862335","DOI":"10.3389\/fneur.2022.862335","article-title":"Chronic inflammatory or chronic inflammatory demyelinating polyradiculoneuropathy?","volume":"13","author":"Vallat","year":"2022","journal-title":"Front Neurol"},{"key":"R3-20250124","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/brain\/awx124","article-title":"Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.","volume":"140","author":"Delmont","year":"2017","journal-title":"Brain"},{"key":"R4-20250124","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/brain\/awy134","article-title":"Subacute nodopathy with conduction blocks and anti-neurofascin 140\/186 antibodies: an ultrastructural study.","volume":"141","author":"Vallat","year":"2018","journal-title":"Brain"},{"key":"R5-20250124","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1212\/WNL.0000000000004773","article-title":"Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies.","volume":"90","author":"Burnor","year":"2018","journal-title":"Neurology"},{"key":"R6-20250124","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/mus.26493","article-title":"Neurofascin-140 and -155 antibodies in an atypical case of POEMS syndrome.","volume":"60","author":"Rempe","year":"2019","journal-title":"Muscle Nerve"},{"key":"R7-20250124","doi-asserted-by":"crossref","first-page":"e603","DOI":"10.1212\/NXI.0000000000000603","article-title":"Anti-pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy.","volume":"6","author":"Stengel","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R8-20250124","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.neucli.2020.09.007","article-title":"Anti-pan-neurofascin IgM in COVID-19-related Guillain-Barr\u00e9 syndrome: evidence for a nodo-paranodopathy.","volume":"50","author":"Tard","year":"2020","journal-title":"Neurophysiol Clin"},{"key":"R9-20250124","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1002\/mus.26851","article-title":"Motor neuropathy with conduction block due to pan-neurofascin antibodies in a patient with chronic lymphocytic leukemia.","volume":"61","author":"Li","year":"2020","journal-title":"Muscle Nerve"},{"key":"R10-20250124","doi-asserted-by":"crossref","first-page":"e763","DOI":"10.1212\/NXI.0000000000000763","article-title":"Antibodies to nodal\/paranodal proteins in paediatric immune-mediated neuropathy.","volume":"7","author":"De Simoni","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R11-20250124","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/jns.12465","article-title":"Report of a fulminant anti-pan-neurofascin-associated neuropathy responsive to rituximab and bortezomib.","volume":"26","author":"Fels","year":"2021","journal-title":"J Peripher Nerv Syst"},{"key":"R12-20250124","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/jnnp-2021-326343","article-title":"IgG(1) pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality.","volume":"92","author":"Fehmi","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R13-20250124","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1111\/ene.15266","article-title":"Daratumumab for treatment-refractory antibody-mediated diseases in neurology.","volume":"29","author":"Scheibe","year":"2022","journal-title":"Eur J Neurol"},{"key":"R14-20250124","doi-asserted-by":"crossref","first-page":"1028282","DOI":"10.3389\/fimmu.2022.1028282","article-title":"Case report: autoimmune nodopathy with concurrent serum and CSF IgG4 anti-neurofascin 155 antibodies.","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"R15-20250124","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1093\/brain\/awac418","article-title":"Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damage.","volume":"146","author":"Appeltshauser","year":"2023","journal-title":"Brain"},{"key":"R16-20250124","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/dmcn.15493","article-title":"Antineurofascin IgG2-associated paediatric autoimmune nodopathy.","volume":"65","author":"Harris","year":"2023","journal-title":"Dev Med Child Neurol"},{"key":"R17-20250124","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/WCO.0000000000001195","article-title":"Pan-neurofascin autoimmune nodopathy - a life-threatening, but reversible neuropathy.","volume":"36","author":"Appeltshauser","year":"2023","journal-title":"Curr Opin Neurol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T23:00:56Z","timestamp":1737759656000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041304","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]}}}